TOFACITINIB Devatis cpr pellic 5 mg 56 pce

7680692130013 Pharmacode 1157476 CH-69213 L04AF01 07.15.0.

Active substances:

TOFACITINIB Devatis cpr pellic 5 mg 56 pce
TOFACITINIB Devatis cpr pellic 5 mg 56 pce
TOFACITINIB Devatis cpr pellic 5 mg 56 pce
1 / 3
google

Details

GTIN
7680692130013
Pharmacode
1157476
Product number
6921301
CPT
-
Packaging group
56
Unit
Tablette(n)
Composition
tofacitinibum 5 mg ut tofacitinibi citras, cellulosum microcristallinum, lactosum monohydricum, carmellosum natricum conexum corresp. natrium 0.54 mg, magnesii stearas, Überzug: hypromellosum, E 171, lactosum monohydricum, macrogolum 3350, triacetinum, pro compresso obducto corresp. lactosum monohydricum 62.57 mg.

Articles (1)

Tofacitinib Devatis 5 mg, Filmtabletten
Filmtabletten
56
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/05/2026
Patient information leaflet
Français
16/05/2026
Patient information leaflet
Italien
16/05/2026
Professional SmPC
Allemand
16/05/2026
Professional SmPC
Français
16/05/2026
Professional SmPC
Italien
16/05/2026

Detailed composition

Substance Quantity Type Category
tofacitinibum
5.0 MG Substance Wirkstoff (Principe actif)
tofacitinibi citras
- Substance WIZUS
cellulosum microcristallinum
- Substance HNIDK
lactosum monohydricum
- Substance HBESI
carmellosum natricum conexum
- Substance HNIDK
natrium
0.54 MG Substance HBESI
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
E 171
- Substance FNIDK
lactosum monohydricum
- Substance HBESI
macrogolum 3350
- Substance HNIDK
triacetinum
- Substance HNIDK
lactosum monohydricum
62.57 MG Substance HBESI

Reimbursement information

Public price
CHF 422.05
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/02/2026

Authorization holder

Devatis AG

6330 Cham

Authorization information

Swissmedic authorization number
69213
Drug name
Tofacitinib Devatis, Filmtabletten
Galenic form
FILM
ATC Code
L04AF01
Authorization status
Z
Dispensation category
B
First authorization
19/06/2025
Authorization expiration date
18/06/2030
IT number
07.15.0.
Domain
Human medicine
Field of application
Selektives Immunsuppressivum

Packaging details

Description (FR)
TOFACITINIB Devatis cpr pellic 5 mg 56 pce
Description (DE)
TOFACITINIB Devatis Filmtabl 5 mg 56 Stk
Market launch
01/01/2026
Narcotic (BTM)
No

Original drug

Xeljanz, Filmtabletten
CHF 460.30
View original

Other packaging sizes

TOFACITINIB Devatis cpr pellic 10 mg 56 pce
56 TABL
View
Buy us a coffee Explore the data